I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Combination of verteporfin-photodynamic therapy with 5-aza-..:
Shramana M. Banerjee
;
Pilar Acedo
;
Soha El Sheikh
...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1188087/full. , 2023
Link:
https://doi.org/10.3389/fimmu.2023.1188087
RT Journal T1
Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:1572abac73e84cec98610f50c614ead0&Exemplar=1&LAN=DE A1 Shramana M. Banerjee A1 Pilar Acedo A1 Soha El Sheikh A1 Rania Harati A1 Amelia Meecham A1 Norman R. Williams A1 Gareth Gerard A1 Mohammed R. S. Keshtgar A1 Alexander J. MacRobert A1 Rifat Hamoudi PB Frontiers Media S.A. YR 2023 K1 verteporfin K1 photodynamic therapy K1 5-aza-2'-deoxycytidine K1 anti-tumour immune response K1 triple negative breast cancer K1 4T1 K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.frontiersin.org/articles/10.3389/fimmu.2023.1188087/full LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2023.1188087 DO https://doi.org/10.3389/fimmu.2023.1188087 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)